The Kentucky Journal
SEE OTHER BRANDS

The top news stories from Kentucky

The Kentucky Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Kentucky Journal.

Press releases published on August 4, 2025

Family Scholar House, MMY US Ribbon Cutting for First Cold-Form Steel, Modular, Volumetric, LEED Platinum Home in US.

Family Scholar House, MMY US Ribbon Cutting for First Cold-Form Steel, Modular, Volumetric, LEED Platinum Home in US.

Ribbon cutting at 11:30 AM Tuesday, August 5, at 913 South 42nd Street, Louisville, KY for the first single-family home developed by Family Scholar House. LOUISVILLE, KY, UNITED STATES, August 4, 2025 /⁨EINPresswire.com⁩/ -- At 11:30 AM on Tuesday, August …

Patients from the USA, Canada and EU Are Traveling to Louisville KY [Kentuckiana] for Dr. Cruz’s Brain Trauma Therapy

Patients from the USA, Canada and EU Are Traveling to Louisville KY [Kentuckiana] for Dr. Cruz’s Brain Trauma Therapy

LOUISVILLE, KY, UNITED STATES, August 4, 2025 /⁨EINPresswire.com⁩/ -- Patients with traumatic brain injuries (TBI) and stroke symptoms are finding new hope in Louisville, Kentucky, where Dr. Rafael F. Cruz MD and his team at Kentuckiana Integrative …

First Fully Approved Medical Cannabis Dispensary to Host Patient Drive Event on August 9, 2025, in Beaver Dam, KY

First Fully Approved Medical Cannabis Dispensary to Host Patient Drive Event on August 9, 2025, in Beaver Dam, KY

The Post Dispensary, the first fully approved medical cannabis dispensary in Kentucky, is hosting a Patient Drive Event on August 9th in Beaver Dam, KY. BEAVER DAM, KY, UNITED STATES, August 4, 2025 /⁨EINPresswire.com⁩/ -- The Post Dispensary, the first …

Onco360® Has Been Selected as a Specialty Pharmacy Partner for LYNOZYFIC™ (linvoseltamab-gcpt)

Onco360® Has Been Selected as a Specialty Pharmacy Partner for LYNOZYFIC™ (linvoseltamab-gcpt)

LOUISVILLE, Ky., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Onco360®, the nation’s leading independent Specialty Pharmacy, has been selected as a national pharmacy partner by Regeneron Pharmaceuticals for Lynozyfic™ (linvoseltamab-gcpt), which has been has granted …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions